Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

Second Sight Medical Products, Inc. (EYES)

(Delayed Data from NSDQ)

$0.99 USD

+0.01 (0.58%)

Updated May 3, 2019 04:00 PM ET

After-Market: $1.00 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.03%
2	Buy	17.70%
3	Hold	9.37%
4	Sell	5.03%
5	Strong Sell	2.48%
S&P	500	11.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

5 items in cart

View Cart/Checkout

Vivani Medical, Inc. [EYES]

Reports for Purchase

Showing records 1 - 20 ( 49 total )

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 1

03/30/2021

Pages: 10

ValuEngine Detailed Valuation Report for EYES

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 2

12/31/2020

Pages: 4

Terminating Coverage

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 3

04/01/2020

Pages: 4

Winding Down Operations; Revising Rating to Under Review From Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 4

03/20/2020

Pages: 5

Early Feasibility Study for Orion Complete; Revising Price Target to Reflect Reverse Split

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 5

11/15/2019

Pages: 4

FDA Agreement on Orion Efficacy Endpoint Reached; 3Q19 Results Update

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 6

08/07/2019

Pages: 4

Orion Discussions With FDA Ongoing; 2Q19 Results Update

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 7

05/16/2019

Pages: 5

All in on Orion; 1Q19 Results Overview

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 8

03/14/2019

Pages: 5

Scaling Back Argus II And Better-Sighted RP Expectations; Lowering Price Target to $2.50

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 9

01/08/2019

Pages: 3

Orion Feasibility Study Progresses; Steps Toward Strengthening Balance Sheet; Maintain Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 10

11/08/2018

Pages: 5

Orion Is Now Used by Patients at Home; 3Q18 Results Overview

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 11

08/08/2018

Pages: 5

Emphasis on Orion; 2Q18 Results Overview

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 12

05/15/2018

Pages: 5

Orion Data Is Big 2H18 Catalyst; Argus II Implants Steadier in US

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 13

02/05/2018

Pages: 3

Strong 4Q17 Implants; Execution Around Key Catalysts Underway

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 14

11/06/2017

Pages: 5

Orion Gets Go Ahead on Human Clinical Study; 3Q17 Results Overview; Affirm Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 15

10/17/2017

Pages: 3

German Study Toward Argus II Approval Progresses; Affirm Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 16

08/29/2017

Pages: 3

Orion Receives Conditional Approval for Feasibility Study; Affirm Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 17

08/08/2017

Pages: 5

Commercialization Execution Coming Through; Orion Related Catalysts Should Drive 2H17

Provider: Rodman & Renshaw, Co.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 18

08/08/2017

Pages: 5

Commercialization Execution Coming Through; Orion Related Catalysts Should Drive 2H17

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 19

07/06/2017

Pages: 3

Expansion of Medicare Coverage in U.S. and Entry Into South Korean Market; Affirm Buy

Provider: Rodman & Renshaw, Co.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

Company: Vivani Medical, Inc.

Industry: Medical - Instruments

Record: 20

07/06/2017

Pages: 3

Expansion of Medicare Coverage in U.S. and Entry Into South Korean Market; Affirm Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DAYAL A

Price: 10.00

Research Provided by a Third Party

previous
1
2
3
next

// eof